Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2024
|
Daveen Chopra CVP, TMTT |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+18.02%
|
-
|
|
May 07
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
857
-3.46%
|
$72,845
$85.6 P/Share
|
|
May 07
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-2.31%
|
$49,810
$85.09 P/Share
|
|
May 07
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
857
+3.27%
|
$30,852
$36.75 P/Share
|
|
May 07
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
7,560
+14.18%
|
-
|
|
May 07
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-1.28%
|
$52,615
$85.09 P/Share
|
|
May 07
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
6,700
+12.17%
|
-
|
|
May 07
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-0.78%
|
$51,765
$85.09 P/Share
|
|
May 07
2024
|
Catherine M. Szyman CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct |
32,025
+29.21%
|
-
|
|
May 07
2024
|
Wayne Markowitz GM & SVP, Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
3,350
+23.93%
|
-
|
|
May 07
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-1.02%
|
$15,130
$85.09 P/Share
|
|
May 07
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,445
+12.27%
|
-
|
|
May 07
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
790
-2.43%
|
$67,150
$85.09 P/Share
|
|
May 07
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,075
+25.39%
|
-
|
|
May 07
2024
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
647
-0.81%
|
$54,995
$85.09 P/Share
|
|
May 07
2024
|
Bernard J Zovighian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,500
+29.43%
|
-
|
|
May 07
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-0.31%
|
$59,075
$85.09 P/Share
|
|
May 07
2024
|
Larry L Wood Global President TAVR & Surg |
BUY
Grant, award, or other acquisition
|
Direct |
8,725
+3.73%
|
-
|
|
May 07
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.02%
|
$3,910
$85.09 P/Share
|
|
May 07
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
7,125
+3.71%
|
-
|
|
May 06
2024
|
Bernard J Zovighian CEO |
BUY
Open market or private purchase
|
Indirect |
580
+15.08%
|
$49,300
$85.74 P/Share
|
|
May 06
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-0.15%
|
$22,015
$85.25 P/Share
|
|
May 04
2024
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,718
-7.35%
|
$316,030
$85.25 P/Share
|
|
May 04
2024
|
Bernard J Zovighian CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,265
+11.03%
|
-
|
|
May 04
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
3,475
-7.7%
|
$295,375
$85.25 P/Share
|
|
May 04
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,855
+11.48%
|
-
|
|
May 04
2024
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,321
-8.54%
|
$197,285
$85.25 P/Share
|
|
May 04
2024
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,713
+14.78%
|
-
|
|
May 04
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
3,541
-1.61%
|
$300,985
$85.25 P/Share
|
|
May 04
2024
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
6,675
+2.94%
|
-
|
|
May 04
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,157
+2.28%
|
-
|
|
May 04
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-1.69%
|
$24,735
$85.25 P/Share
|
|
May 04
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-0.79%
|
$10,200
$85.25 P/Share
|
|
May 04
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
3,442
-7.02%
|
$292,570
$85.25 P/Share
|
|
May 04
2024
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,796
+10.57%
|
-
|
|
May 04
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,431
-17.1%
|
$376,635
$85.25 P/Share
|
|
May 04
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,465
+22.37%
|
-
|
|
May 03
2024
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-1.18%
|
$44,795
$85.06 P/Share
|
|
May 03
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.2%
|
$40,715
$85.06 P/Share
|
|
May 03
2024
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-1.28%
|
$24,735
$85.06 P/Share
|
|
May 03
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.18%
|
$33,575
$85.06 P/Share
|
|
May 03
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.02%
|
$3,145
$85.06 P/Share
|
|
May 03
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.61%
|
$23,885
$85.06 P/Share
|
|
May 03
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.69%
|
$9,010
$85.06 P/Share
|
|
May 03
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.1%
|
$40,715
$85.06 P/Share
|
|
May 03
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-3.32%
|
$53,890
$85.06 P/Share
|
|
May 02
2024
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-57.67%
|
$2,465,400
$84.8 P/Share
|
|
May 02
2024
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
May 01
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
14,400
-3.86%
|
$1,209,600
$84.47 P/Share
|
|
May 01
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,400
+7.11%
|
$518,400
$36.75 P/Share
|